Published on Canadian Women's Health Network (https://cwhn.ca)

Home > Printer-friendly

Unsafe by any name

Tagged :
Print [13]
Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
Carla Marcelis
Mira Shiva
Edition: 
Vol 7, No.4
Publisher: 
Women Healthsharing
Publication Date: 
1986
Publication Place: 
Toronto, ON

This article discusses how the marketing of controversial drugs in developing countries demonstrates the power and priorities of the pharmaceutical industry. Example highlighted: Estrogen-Progesterone combination drugs. 

Available From: 
Canadian Women's Health Network [14]
URLs: 
http://www.cwhn.ca/sites/default/files/PDF/Healthsharing/1986_Healthsharing_Vol_7_No_4_Fall.pdf [15]
Source URL: https://cwhn.ca/en/node/46444

Links:
[1] https://cwhn.ca/en/taxonomy/term/3031
[2] https://cwhn.ca/en/taxonomy/term/5498
[3] https://cwhn.ca/en/taxonomy/term/4180
[4] https://cwhn.ca/en/taxonomy/term/5697
[5] https://cwhn.ca/en/taxonomy/term/3547
[6] https://cwhn.ca/en/taxonomy/term/3663
[7] https://cwhn.ca/en/taxonomy/term/3021
[8] https://cwhn.ca/en/taxonomy/term/3661
[9] https://cwhn.ca/en/taxonomy/term/4147
[10] https://cwhn.ca/en/taxonomy/term/6119
[11] https://cwhn.ca/en/taxonomy/term/3899
[12] https://cwhn.ca/en/taxonomy/term/6124
[13] https://cwhn.ca/print/46444
[14] https://cwhn.ca/en/node/15818
[15] http://www.cwhn.ca/sites/default/files/PDF/Healthsharing/1986_Healthsharing_Vol_7_No_4_Fall.pdf